5% Off
Nab-Xelpac100 mg/via
Beacon Pharmaceuticals PLC
৳23750.00
Add to cart
Generic medicine
Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel]: Brands, Price & Uses in Bangladesh
Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is a cytotoxic chemotherapy agent administered by an oncologist in a hospital or cancer-center infusion setting.
About Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel]
Indications of Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel]
Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is a cytotoxic chemotherapy agent administered by an oncologist in a hospital or cancer-center infusion setting. Its indications are classified below by strength of evidence.
Established / FDA-approved indications
- Metastatic breast cancer (single agent): after failure of combination chemotherapy for metastatic disease, or relapse within 6 months of adjuvant chemotherapy; prior therapy should generally have included an anthracycline unless clinically contraindicated.
- Locally advanced or metastatic non-small cell lung cancer (NSCLC): first-line treatment, used in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.
- Metastatic adenocarcinoma of the pancreas: first-line treatment, used in combination with gemcitabine.
Off-label use (not FDA-approved, used based on limited evidence/guideline discretion)
- Advanced epithelial ovarian cancer and other solid tumors where taxane-based therapy is indicated, at the treating oncologist's discretion.
Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is never a first-choice, self-selected medicine; the treating oncologist determines whether it is appropriate for a given cancer type, stage, and combination regimen.
Dosage & Administration of Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel]
Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is administered only as an intravenous infusion by trained oncology healthcare professionals, with dosing individualized by indication, body surface area (BSA), and the patient's blood counts and tolerance. Routine premedication to prevent hypersensitivity reactions is generally not required with Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel], unlike solvent-based paclitaxel, because it does not contain Cremophor EL.
| Indication | Typical adult regimen |
|---|---|
| Metastatic breast cancer | 260 mg/m² IV over approximately 30 minutes, once every 3 weeks |
| Non-small cell lung cancer (with carboplatin) | 100 mg/m² IV over approximately 30 minutes on Days 1, 8, and 15 of a 21-day cycle, with carboplatin given on Day 1 |
| Pancreatic adenocarcinoma (with gemcitabine) | 125 mg/m² IV over approximately 30–40 minutes on Days 1, 8, and 15 of a 28-day cycle, followed by gemcitabine |
Doses of Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] are withheld, reduced, or delayed based on neutrophil counts, platelet counts, peripheral neuropathy grade, and hepatic function, per the treating oncologist's assessment at each cycle. Complete blood counts must be monitored before each dose.
Side Effects of Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel]
Side effects of Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] are common given its cytotoxic mechanism and are monitored closely by the oncology team throughout treatment.
Very common
- Alopecia (hair loss)
- Neutropenia, anemia, thrombocytopenia (see Precautions for myelosuppression monitoring)
- Peripheral neuropathy (numbness, tingling in hands/feet; see Precautions)
- Fatigue and asthenia
- Nausea, vomiting, diarrhea
- Myalgia and arthralgia
- Elevated liver enzymes
Less common but clinically important
- Infections related to neutropenia
- Mucositis/stomatitis
- Peripheral edema
- Hypersensitivity reactions (usually mild given the absence of solvent; see Precautions)
- Cardiac arrhythmias (uncommon)
Contraindications of Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel]
Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is contraindicated in patients with:
- Known hypersensitivity to paclitaxel or to human albumin.
- Baseline neutrophil counts below the labeled threshold (baseline neutrophil count <1,500 cells/mm³) for the intended regimen, until counts recover.
- Pregnancy: Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is a cytotoxic, teratogenic agent and is contraindicated during pregnancy due to the risk of fetal harm.
Frequently Asked Questions about Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel]
What is Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] used for?
Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is a chemotherapy medicine used to treat metastatic breast cancer, non-small cell lung cancer (combined with carboplatin), and metastatic pancreatic adenocarcinoma (combined with gemcitabine). It is given only under an oncologist's supervision.
How is Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] given?
Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is given as an intravenous infusion in a hospital or cancer-treatment center, typically over 30 to 40 minutes, on a schedule determined by your cancer type and the specific chemotherapy protocol being followed.
Do I need to take steroid or antihistamine tablets before each dose?
Unlike older solvent-based paclitaxel, Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] does not contain the solvent that causes severe allergic reactions, so routine premedication is usually not required, although your oncology team may still choose to monitor you closely during infusion.
What are the main side effects of Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel]?
Common side effects include hair loss, low blood counts (increasing infection, bleeding, or anemia risk), numbness or tingling in the hands and feet (peripheral neuropathy), fatigue, nausea, and muscle or joint pain. Your care team will monitor your blood counts before every dose.
Can Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] be used during pregnancy?
No. Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is contraindicated in pregnancy because it is a cytotoxic drug that can seriously harm a developing fetus. Effective contraception is recommended during and after treatment, and breastfeeding is not advised during therapy.
What should be done if too much Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is given by mistake?
An overdose of Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel] is a medical emergency. Because it is administered by trained hospital staff with carefully calculated doses, this is rare, but any suspected overdose requires immediate hospital-based supportive care; contact the treating hospital or emergency services right away.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.